In 2021, enterprises invested almost 17 billion in research in Switzerland
Neuchâtel, 19.12.2022 - In 2021, private enterprises in Switzerland spent CHF 16.8 billion on their in-house research and development activities (R&D). This represented an increase of +4% per year since 2019, the year of the last survey. With a total of CHF 6.2 billion, the pharmaceutical sector invested the most in R&D in Switzerland. Almost 62 000 people were involved in R&D activities. A quarter of the workforce was made up of women. These are the main results of a study carried out by the Federal Statistical Office (FSO) in partnership with economiesuisse.
This press release and further information on the topic can be found on the FSO website (see link below).
Address for enquiries
Sandra Plaza Chardon, FSO, Economic Structure and Analyses, tel.: +41 58 463 63 48,
Federal Statistical Office